DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $413,105,000 | +3.0% | 1,599,383 | +1.1% | 1.84% | +6.5% |
| Q2 2022 | $400,997,000 | -8.2% | 1,581,718 | +6.2% | 1.73% | +6.7% |
| Q1 2022 | $436,703,000 | -10.9% | 1,488,777 | -0.0% | 1.62% | -2.5% |
| Q4 2021 | $489,918,000 | +8.5% | 1,489,068 | +0.4% | 1.66% | +2.8% |
| Q3 2021 | $451,588,000 | +3.5% | 1,483,339 | -8.8% | 1.61% | +7.2% |
| Q2 2021 | $436,403,000 | +16.9% | 1,626,186 | -1.9% | 1.51% | +14.2% |
| Q1 2021 | $373,228,000 | -2.9% | 1,658,202 | -4.2% | 1.32% | -4.3% |
| Q4 2020 | $384,317,000 | -1.5% | 1,730,064 | -4.5% | 1.38% | -14.1% |
| Q3 2020 | $390,042,000 | +5.7% | 1,811,368 | -13.2% | 1.60% | +2.8% |
| Q2 2020 | $369,023,000 | +33.8% | 2,086,881 | +4.7% | 1.56% | +8.5% |
| Q1 2020 | $275,878,000 | -6.2% | 1,993,194 | +4.0% | 1.44% | +18.3% |
| Q4 2019 | $294,050,000 | +17.1% | 1,915,886 | +10.2% | 1.22% | +11.8% |
| Q3 2019 | $251,066,000 | +9.9% | 1,738,325 | +8.7% | 1.09% | +6.2% |
| Q2 2019 | $228,458,000 | +10.0% | 1,598,505 | +1.6% | 1.02% | +3.0% |
| Q1 2019 | $207,688,000 | +21.3% | 1,573,152 | -5.3% | 1.00% | +4.8% |
| Q4 2018 | $171,273,000 | -6.4% | 1,660,905 | -1.3% | 0.95% | +11.6% |
| Q3 2018 | $182,897,000 | +6.3% | 1,683,203 | -3.5% | 0.85% | -1.7% |
| Q2 2018 | $172,114,000 | -2.1% | 1,744,162 | -2.9% | 0.86% | -4.8% |
| Q1 2018 | $175,885,000 | +4.8% | 1,796,394 | -0.6% | 0.91% | +3.2% |
| Q4 2017 | $167,825,000 | +1.1% | 1,808,073 | -6.5% | 0.88% | -6.2% |
| Q3 2017 | $165,957,000 | +18.9% | 1,934,685 | +17.0% | 0.94% | +14.8% |
| Q2 2017 | $139,552,000 | +33.6% | 1,653,647 | +35.4% | 0.82% | +27.4% |
| Q1 2017 | $104,427,000 | +5.7% | 1,220,944 | -3.8% | 0.64% | +1.9% |
| Q4 2016 | $98,777,000 | -0.1% | 1,268,967 | +0.6% | 0.63% | -4.0% |
| Q3 2016 | $98,872,000 | -26.1% | 1,261,280 | -4.8% | 0.66% | -26.6% |
| Q2 2016 | $133,872,000 | +23.2% | 1,325,469 | +15.7% | 0.89% | +15.5% |
| Q1 2016 | $108,683,000 | +9.2% | 1,145,721 | +6.9% | 0.77% | +6.2% |
| Q4 2015 | $99,518,000 | +0.6% | 1,071,462 | -7.7% | 0.73% | -1.9% |
| Q3 2015 | $98,945,000 | -12.2% | 1,161,194 | -11.8% | 0.74% | -3.0% |
| Q2 2015 | $112,648,000 | -13.3% | 1,316,140 | -14.0% | 0.77% | -13.2% |
| Q1 2015 | $129,878,000 | -4.3% | 1,529,775 | -3.4% | 0.88% | -5.5% |
| Q4 2014 | $135,727,000 | +8.0% | 1,583,557 | -4.2% | 0.93% | +3.3% |
| Q3 2014 | $125,636,000 | -5.9% | 1,653,536 | -2.5% | 0.90% | -1.0% |
| Q2 2014 | $133,499,000 | +1.0% | 1,695,656 | -3.8% | 0.91% | +0.2% |
| Q1 2014 | $132,169,000 | -9.7% | 1,762,256 | -7.1% | 0.91% | -5.2% |
| Q4 2013 | $146,430,000 | +6.9% | 1,896,763 | -4.0% | 0.96% | -1.1% |
| Q3 2013 | $136,929,000 | -12.7% | 1,975,313 | -20.3% | 0.97% | -18.4% |
| Q2 2013 | $156,817,000 | – | 2,477,357 | – | 1.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |